China Resources Medical Holdings Company Limited (Stock Code: 1515) released details on its board of directors and committee assignments. The board comprises four Executive Directors, one Non-Executive Director, and four Independent Non-Executive Directors. The Executive Directors are led by Chairman Yu Hai, joined by Chief Executive Officer Zhang Chuang, Wang Yuexing, and Vice President Wu Xinchun. Non-Executive Director Ge Lu also serves on the board.

Independent Non-Executive Directors include Wu Ting Yuk, Anthony; Fu Tingmei; Zhou Peng; and Lo Wing Sze. The board has established an Audit Committee, a Nomination Committee, and a Remuneration Committee to oversee various governance responsibilities. According to the announcement, these committees are chaired respectively by Fu Tingmei (Audit Committee), Yu Hai (Nomination Committee), and Wu Ting Yuk, Anthony (Remuneration Committee). Other board members serve as either committee members or chairpersons based on their areas of expertise.

The announcement was issued in the PRC on February 27, 2026 and reiterates the company’s commitment to robust governance through a clearly defined leadership structure, covering executive management, board oversight, and independent review by external directors.